A5G (p.Ala5Gly) variant of NFKBIA (NF-kappa-B inhibitor alpha)
A5G (p.Ala5Gly) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The record also includes variant effect predictions and structural context.
A5G (p.Ala5Gly) variant details
- p.Ala5Gly
- Ensembl rs2052771143
- Uncertain significance
- Missense
- MetaLR 0.23
- MetaSVM -0.86
- SIFT 0.20
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available